Mol. Hum. Reprod. Advance Access originally published online on April 3, 2009
Molecular Human Reproduction 2009 15(7):433-442; doi:10.1093/molehr/gap029
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Protein processing by the placental protease, cathepsin P
1Department of Biomedical Research, Alfred I duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19803, USA 2Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA
4 Correspondence address. E-mail: rmason{at}nemours.org
Cathepsin P is a member of a family of placentally expressed cathepsins (PECs). The closest human homolog of cathepsin P is cathepsin L, a broad specificity enzyme that has functions in many tissues in addition to placenta. The gene duplications that gave rise to the PECs provide a rare opportunity to define proteolytic functions in placenta, a transient organ unique to mammals. Peptidyl substrate and inhibitor libraries have shown that cathepsin P has evolved an unusually restricted preference for substrates containing hydrophobic amino acids. Proteomic techniques were used to probe for substrates of this enzyme. Recombinant cathepsin P was incubated with rat choriocarcinoma (Rcho-1) cell proteins to identify substrates using two-dimensional difference gel electrophoresis. Substrate proteins were excised from gels and characterized by trypsin digestion and MALDI MS/MS. Two endoplasmic reticulum (ER) proteins, gp96 and calreticulin, emerged as potential substrates, and western blotting showed that these proteins are processed by cathepsin P from their C-terminus, removing the KDEL ER retention signal. Immunohistochemistry showed that a portion of cathepsin P co-localizes with calreticulin in Rcho-1 cells. Extracellular calreticulin induces differentiation of Rcho-1 cells, indicating a potential role of cathepsin P in processing and secretion of calreticulin during differentiation of trophoblast giant cells.
Key words: placenta/cathepsin/proteolysis/processing
3 Present address: Department of Cancer Biology, PRB447, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN 37232, USA
Submitted on November 21, 2008; resubmitted on March 18, 2009; accepted on April 1, 2009.